DekaBank Deutsche Girozentrale’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-78,200	Closed	-$2.8M	–	1442
2021 Q2	$2.8M	Hold	78,200	–	–	0.01%	656
2021 Q1	$1.88M	Hold	78,200	–	–	0.01%	715
2020 Q4	$1.73M	Sell	78,200 -3,900	-5%	-$85.9K	0.01%	698
2020 Q3	$1.5M	Buy	+82,100	New	+$1.7M	0.01%	659
2019 Q4	–	Sell	-23,000	Closed	-$349K	–	1250
2019 Q3	$349K	Sell	23,000 -23,000	-50%	-$329K	﹤0.01%	807
2019 Q2	$724K	Buy	+46,000	New	+$626K	﹤0.01%	854
2019 Q1	–	Sell	-23,000	Closed	-$233K	–	1278
2018 Q4	$233K	Buy	+23,000	New	+$303K	﹤0.01%	946

Other funds holding DRNA

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

DekaBank Deutsche Girozentrale's DRNA Position: Q3 2021 in Review

DekaBank Deutsche Girozentrale sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q3 2021, closing a stake of 78,200 shares — an estimated $2.8M sold.

DekaBank Deutsche Girozentrale first reported a position in DRNA in Q4 2018 and held it in 7 quarters. The position peaked at $2.8M in Q2 2021. 173 funds tracked by Wall St. Rank hold DRNA as of Q3 2021.

DekaBank Deutsche Girozentrale reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 78,200 Dicerna Pharmaceuticals, Inc. shares in Q3 2021, an estimated $2.8M.
DekaBank Deutsche Girozentrale first reported a position in Dicerna Pharmaceuticals, Inc. in Q4 2018 and held it in 7 quarters.
DekaBank Deutsche Girozentrale's Dicerna Pharmaceuticals, Inc. position peaked at $2.8M in Q2 2021.
173 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q3 2021.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2021, filed 22 Oct 2021.